Precision cancer tests encompass imaging and in vitro diagnostic (IVD) products and procedures that directly detect malignancies in patient samples or in the patients themselves.
This report contains market size and forecasts of Precision Cancer Diagnostic Tests in Global, including the following market information:
- Global Precision Cancer Diagnostic Tests Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global top five companies in 2021 (%)
The global Precision Cancer Diagnostic Tests market was valued at 4268.7 million in 2021 and is projected to reach US$ 9414.6 million by 2028, at a CAGR of 12.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Imaging Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Precision Cancer Diagnostic Tests include Abbott Laboratories, Agilent Technologies, Becton Dickinson and Company, Bio-Rad Laboratories, Biocartis N.V., Biocept, bioMerieux SA, Canon Medical Systems Corporation and Cynvenio Biosystems, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Precision Cancer Diagnostic Tests companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Precision Cancer Diagnostic Tests Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Precision Cancer Diagnostic Tests Market Segment Percentages, by Type, 2021 (%)
- Imaging
- Molecular
- Histology/Cytology
- Tumor Marker Immunoassays
- POC Colon Cancer Tests
Global Precision Cancer Diagnostic Tests Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Precision Cancer Diagnostic Tests Market Segment Percentages, by Application, 2021 (%)
Global Precision Cancer Diagnostic Tests Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Precision Cancer Diagnostic Tests Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Precision Cancer Diagnostic Tests revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Precision Cancer Diagnostic Tests revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Abbott Laboratories
- Agilent Technologies
- Becton Dickinson and Company
- Bio-Rad Laboratories
- Biocartis N.V.
- Biocept
- bioMerieux SA
- Canon Medical Systems Corporation
- Cynvenio Biosystems
- Danaher Corporation
- Epigenomics AG
- Exosome Diagnostics
- Foundation Medicine
- General Electric Company
- Genomic Health
- Hologic
- Illumina
- Menarini Silicon Biosystems SpA
- Myriad Genetics
- NanoString Technologies
- Ortho Clinical Diagnostics
- QIAGEN N.V.
- Randox Laboratories Ltd.
- Roche Holding AG
- Royal Philips N.V.
- Siemens AG
- Thermo Fisher Scientific
- Vela Diagnostics
